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Objective—Prevention of Clostridium difficile infection (CDI) in acute care hospitals is a 
priority for hospitals and clinicians. We performed a qualitative systematic review to update the 
evidence on interventions to prevent CDI published since 2009.
Design—We searched Ovid, MEDLINE, EMBASE, The Cochrane Library, CINAHL, ISI Web of 
Knowledge, and grey literature databases from January 1, 2009 to August 1, 2015.
Setting—We included studies performed in acute care hospitals.
Patients or participants—We included studies conducted on hospitalized patients that 
investigated the impact of specific interventions on CDI rates.
Interventions—We used the QI-Minimum Quality Criteria Set (QI-MQCS) to assess the quality 
of included studies. Interventions were grouped thematically: environmental disinfection, 
antimicrobial stewardship, hand hygiene, chlorhexidine bathing, probiotics, bundled approaches, 
and others. A meta-analysis was performed when possible.
Results—Of 3236 articles screened, 261 met the criteria for full-text review and 46 studies were 
ultimately included. The average quality rating was 82% on the QI-MQCS. The most effective 
interventions, resulting in a 45% to 85% reduction in CDI, included daily to twice daily 
disinfection of high-touch surfaces (including bed rails) and terminal cleaning of patient rooms 
with chlorine-based products. Bundled interventions and antimicrobial stewardship showed 
promise for reducing CDI rates. Chlorhexidine bathing and intensified hand hygiene practices 
were not effective for reducing CDI rates.
Conclusions—Daily and terminal cleaning of patient rooms using chlorine-based products were 
most effective in reducing CDI rates in hospitals. Further studies are needed to identify the 
components of bundled interventions that reduce CDI rates.
Keywords
hospital medicine; healthcare quality improvement; infection control; nosocomial infections; 
quality improvement methodologies; Clostridium difficile
Introduction
Clostridium difficile infection (CDI) is the leading cause of infectious diarrhea acquired in 
the hospital and causes significant morbidity and mortality.1,2 The prevalence of CDI in US 
hospitals is estimated to be 13.of 1000 patients; approximately 75% of cases are hospital 
acquired, and resulting in healthcare expenditures of USD $9,000 – $15,000 per patient, or 
an estimated US $1.5 – 3.2 billion annually.3
The Infectious Diseases Society of America (IDSA) and Society for Healthcare 
Epidemiology of America (SHEA) published practice recommendations to reduce CDI in 
acute care hospitals, and these recommendations have been widely endorsed.4,5 Despite 
these efforts, the incidence of CDI continues to increase, and a new strain of C. difficile has 
emerged and is associated with more severe disease.1
The most recent qualitative systematic review of CDI prevention in hospitals, published in 
2009,6 concluded that antimicrobial stewardship programs (ASPs), glove use, hand hygiene, 
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and disposable thermometers should be used routinely. However, the review noted a lack of 
substantial evidence for other measures such as environmental cleaning or patient isolation. 
The goal of this systematic review is to update the evidence on interventions to reduce CDI 
in acute care hospitals, encompassing hospital onset and hospital-acquired CDI.
Methods
Data Sources and Keywords
We systematically searched for controlled trials of interventions to reduce the rate of CDI in 
acute care hospitals, using the biomedical electronic databases Ovid, MEDLINE, EMBASE, 
The Cochrane Library, CINAHL, and ISI Web of Knowledge. We searched for articles 
published between January 1, 2009, and August 1, 2015. Sets of relevant terms representing 
“Clostridium difficile” and “prevention” were obtained from subject headings and free-text 
database fields and combined with the “AND” operator for database searches. The search 
was limited to controlled clinical trials, pre- and post-test studies, controlled before-and-after 
studies, and interrupted time series studies. Additional studies were identified by scanning 
references of relevant publications, using the “Related Articles” feature in PubMed, and 
using the “Cited Reference Search” in the ISI Web of Science. A detailed search strategy is 
provided in Table e1 in the online supplement.
Eligibility Criteria
We included studies that assessed the effect of interventions on the rate of CDI in acute care 
hospitals. Studies must have provided a CDI rate or rate ratio, or data to calculate the rate of 
infection. Studies were excluded if interventions were not performed in an acute care 
hospital, if the intervention was not described in sufficient detail to allow for categorization 
of the intervention, if there was no comparator group, or if follow-up was insufficient to 
allow for evaluation of the effectiveness of the intervention (ie, < 3 months). Secondary 
studies, such as meta-analyses, were excluded.
All titles and abstracts were independently screened by 2 reviewers to identify studies 
potentially eligible for inclusion and a full text review was performed to identify studies 
eligible for data extraction. Disagreements were resolved by consensus. The process was 
documented using a PRISMA FLOW diagram (Figure e1).
Data Extraction
A single reviewer performed the data extraction. A random 50% of the studies were checked 
by a second reviewer for accuracy. Studies were coded by type and category of intervention. 
Categories were approved by consensus.
Quality Assessment
Most studies were nonrandomized trials and quality improvement-focused studies, 2 
reviewers independently used the QI-Minimum Quality Criteria Set (QI-MQCS) tool7 to 
evaluate the quality of studies. This tool, in contrast with the more general Grading of 
Recommendations Assessment, Development and Evaluation, provides a quantitative 
comparative evaluation of the studies.
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Literature Search and Review Process
We reviewed the titles and abstracts of 3,246 articles for relevance and selected 261 for full-
text review. Of these, 215 articles were excluded for reasons provided in Online 
Supplemental Figure e1. We coded the remaining 46 studies into intervention categories: 
environmental disinfection, antimicrobial stewardship, hand hygiene, chlorhexidine bathing, 
probiotics, bundled approaches, and other interventions.
Description of Studies and Study Quality
An aggregate description of the included studies is given in Table 1. The studies encompass 
233 hospitals, mostly from the United States. Most hospitals had >200 beds.
The average score of the studies on the QI-MQCS was 82% (Online Table e2), suggesting 
fair to good quality.
Efficacy of Interventions
To detect heterogeneity in the data, we conducted a quantitative meta-analysis of the efficacy 
of interventions for reducing CDI rates. There was significant heterogeneity between the 
studies, as evidenced by I2 > 98% both for the whole group and individual intervention 
groupings. Further subgroup analyses and meta-regressions using variables, such as hospital 
size and type, components of bundled interventions, year of publication, and location of 
intervention (whole hospital versus specific units) were unable to explain the heterogeneity 
between the studies. Therefore, we only present a qualitative systematic review of the 
evidence.
Interventions
Environmental disinfection interventions—The 5 studies on environmental 
disinfection used a variety of interventions: daily bleach disinfection with auditing, terminal 
room disinfection with hydrogen peroxide vapor, terminal room ultraviolet light (UV) 
treatment, and complete surface terminal bleach disinfection (Online Table e3). Among 
these interventions, daily and terminal disinfection of the patient room with bleach-
containing products in conjunction with auditing led to significant reduction in CDI. 
Orenstein et al.8 instituted daily bleach disinfection of patient rooms and high-touch surfaces 
with intensive auditing, reducing the rate of CDI from 24.2 of 10,000 to 3.6 of 10,000 
patient-days. Hacek et al.9 instituted terminal bleach disinfection, including disinfection of 
the walls and unannounced audits by the institution’s infection prevention committee. These 
measures reduced the rate of CDI from 8.5 of 10,000 to 4.6 of 10,000 patient-days.
Terminal cleaning with UV light in addition to bleach cleaning had uncertain efficacy. Levin 
et al.10 used pulsed UV treatment in addition to terminal bleach cleaning and disinfection of 
rooms previously occupied by CDI patients. With treatment of 96% of the patient rooms, 
they observed a decrease in the rate of CDI from 9.46 of 10,000 to 4.45 of 10,000 patient-
days. Haas et al.11 instituted pulsed UV treatment in addition to terminal bleach disinfection 
in a large urban hospital, with minimal incremental reduction in CDI rates.
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Antimicrobial stewardship programs—We identified 13 studies that implemented 
ASPs, such as a system of prospective audit and feedback when targeted antimicrobials were 
prescribed, or preauthorization requirements for antimicrobials. Both methods appeared to 
be effective in reducing CDI in acute care hospitals. Yam et al.12 demonstrated a decrease in 
CDI rates from 8.2 of 10,000 to 3.1 of 10,000 patient-days with an audit and feedback 
system for 6 high-risk antimicrobials, although this result may be confounded by a change in 
environmental cleaning practice made immediately preceding this evaluation. Similarly, 
Dancer et al.13 implemented stewardship educational lectures and restricted use of 
ceftriaxone and ciprofloxacin, resulting in CDI reduction from 24 of 10,000 to 5.5 of 10,000 
patient-days. Hospitals with relatively low baseline rates of CDI did not see a substantial 
change after deployment of an ASP.14,15
Hand hygiene studies—We reviewed 4 studies that evaluated the effect of hand hygiene 
campaigns. Kirkland et al.,16 Doron et al.,17 and Stone et al.18 used multifaceted campaigns 
that included access to alcohol-based hand rub, education, auditing, and feedback of hand 
hygiene compliance, in addition to advertising the use of hand hygiene. Stone et al.18 
described a significant reduction in CDI after a nationwide hand hygiene campaign in 
hospitals in England and Wales, but studies that investigated single-hospital campaigns 
showed no change in C. difficile acquisition.16,17
Knight et al.19 found that a hospital-wide policy advocating alcohol-based hand rub instead 
of soap and water significantly reduced CDI in acute care hospitals, even though alcohol-
based hand rub does not eradicate spores of C. difficile. The researchers hypothesized that 
improved hand hygiene compliance may have played a role in CDI reduction.
Chlorhexidine bathing—We reviewed 4 studies that examined daily chlorhexidine 
(CHG) bathing to reduce the risk of hospital-acquired infections, including CDI. Popovich et 
al.20 Noto et al.21 and Kassakian et al.22 evaluated CHG wipes for daily bathing of patients; 
none showed a statistically significant decrease in the rate of CDI.
In contrast, Rupp et al.23 studied CHG solution added to the traditional daily bed bathing 
protocol. A statistically significant decline in CDI was found during the study period, with a 
corresponding increase during a washout period.
Probiotics—Maziade et al.24,25 performed a quasiexperimental study investigating 10 
years of use of a high-dose preparation of Lactobacillus species after failing to reduce CDI 
in acute care hospitals with augmented standard protective measures and reported a CDI rate 
of 2.3 of 10,000 patient-days compared with 7.5 of 10,000 patient-days in similar hospitals 
in the region.24,25 In contrast, an observational study reported no difference in CDI (9.9 of 
10,000 patient days vs 10.4 of 10,000 patient-days) after cessation of twice daily 250 mg 
dosing of Saccharomyces boulardii with antibiotics without changing other C. difficile 
preventive measures.26
Other studies—The universal use of emollient-based gloves, a ventilator-associated 
pneumonia bundle, implementation of electronic medical records to enhance stewardship 
activities, and strict contact precautions were each evaluated by a single study. In the 
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emollient-based glove study, the investigators removed contact precautions and instituted 
universal emollient-based gloving for an 18-bed intensive care unit.27 Despite the removal of 
contact precautions for patients with multidrug-resistant organisms, the CDI rate.did not 
increase. Cook et al.28 demonstrated reduction in antimicrobial use and a decrease in CDI 
rate when existing antimicrobial stewardship activities were enhanced by the institution of 
electronic medical records. Cheng et al.29 used strict contact precautions and also found a 
small reduction in CDI.
Bundled interventions—Overall 14 studies described the implementation of multiple 
interventions either simultaneously or sequentially (Online Table e4). All found significant 
reductions in CDI from baseline.
Abbett et al.30 used a prevention checklist that included contact precautions, patient 
isolation, daily and terminal bleach disinfection, and a treatment checklist that included 
antibiotic guidelines. CDI rates decreased from 11.0 of 10,000 to 6.6 of 10,000 patient-days. 
Miller et al.31 used a checklist to encourage compliance with hand hygiene, contact 
precautions, both daily and terminal bleach disinfection, and UV light disinfection. In 
association with these interventions, CDI rates decreased from 23.3 of 10,000 to 8.3 of 
10,000 patient-days.
Adelyab et al.32 evaluated a restrictive ASP and education and audited daily and terminal 
environmental disinfection with bleach. Similarly, Adelyab et al.33 demonstrated a 
significant reduction in CDI rates after a bundled intervention that included an ASP with 
audit and feedback plus daily and terminal environmental disinfection with bleach. Bryce et 
al.34 studied the impact of a risk-managed vancomycin-resistant Enterococci control strategy 
that included an enhanced environment and equipment cleaning program and an ASP 
protocol with audit and feedback. They achieved a significant reduction in CDI rates, from 
12.0 of 10,000 to 5.3 of 10,000 patient days.
Price et al.35 implemented a bundle consisting of antimicrobial restriction and a dedicated 
ward for patients with CDI; they achieved a 47% reduction in CDI (13.0 of 10,000 to 6.9 of 
10,000 patient days). Suzuki et al.36 implemented more stringent isolation requirements, 
more frequent clinical review of patients colonized with multidrug-resistant organisms, and 
more restrictive antimicrobial prescribing guidelines. Rates of CDI fell by > 75% (4.71 of 
10,000 to 1.08 of 10,000 patient days). Pokrywka et al.37 described the addition of a hand 
hygiene intervention to an existing bundle of extended isolation periods, provider education, 
and environmental cleaning protocols, resulting in a 44% decrease in CDI (10.45 of 10,000 
to 6.95 of 10,000 patient days) over the course of 1 year. Brakovich et al.38 also observed 
significant CDI reduction after implementing a bundled intervention that included ASP with 
audited feedback, contact precautions, hand hygiene, and checklist-driven environmental 
cleaning.
Other studies (Weiss et al.,39 You et al.,40 and Salgado et al.41) also found significant 
reductions in CDI following implementation of bundles that focused on contact precautions, 
environmental disinfection, and patient cohorting. Finally, Bishop, et al.42 utilized a 
resident-directed rounding protocol that included limiting the number of team members in 
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patients’ rooms, as well as barrier precautions; these efforts were also associated with a 
reduction in CDI.
Discussion
In comparison with the systematic review by Hsu et al.6 from 2009, we included several new 
categories of interventions in this review, including ASPs, CHG bathing, and UV light 
disinfection. We also included bundled interventions in our protocol; unlike other reviews, 
we categorized ASPs that included other interventions in the bundled category. This 
categorization enables us to provide a more accurate comparison of interventions. We also 
excluded studies that did not report a rate of CDI, and we included studies performed during 
outbreaks. We elected not to combine this review with the Hsu et al.6 review because of 
these differences in eligible studies. The SHEA and the IDSA recommend appropriate use of 
antibiotics; contact precautions; cleaning and disinfection of equipment and environment; 
electronic CDI surveillance with laboratory-based alerts; education of hospital staff, patients, 
and families; and assessment of compliance with hand hygiene and contact precaution 
measures. These recommendations endure despite a low level of evidence for most of these 
interventions.5,43
An expert panel in 2015 also published a “Pathway to Prevention” for CDI by utilizing a 
modified Delphi poll based on an extensive review of literature.3 Although the strength of 
evidence was graded in this consensus, the quality of systematic review of the evidence used 
to develop the categories for the consensus poll was not thoroughly discussed.
In our review of the recent CDI prevention studies performed in acute care hospitals, bleach-
based environmental disinfection and bundled interventions appeared to have the most effect 
in preventing CDI. Daily bleach and terminal disinfection on high-prevalence wards, as 
discussed by Orenstein et al.,8 may be expected to decrease CDI rates by 85%. Terminal 
bleach disinfection alone, conversely, may be expected to decrease CDI rates by 48%. 
Treatment with UV light may reduce CDI approximately by an additional 4%, but may have 
a greater effect size with >95% compliance.
Bundled interventions with environmental efforts appeared to be more effective than those 
without them, except in Suzuki et al.36 study, in which a 77% reduction in CDI was seen 
with strict contact precautions and cohort procedures.
ASPs included prospective auditing, feedback, and restrictive programs across different 
classes of antibiotics. Institutions with higher baseline rates of CDI have reported a greater 
decrease in incidence after ASP initiation. This trend was also noted in a recent meta-
analysis on ASPs;44 however, the meta-analysis included studies we considered bundled. 
Feazal et al.45 conducted a systematic review on ASPs for preventing CDI and found a 
reduced incidence of CDI with restrictive ASPs; however, there was substantial 
heterogeneity among the studies, with some using concurrent environmental cleaning, which 
may have affected the results.
The lack of efficacy of hand hygiene campaigns tested since 2009 was predictable. Although 
older studies have shown a significant reduction in nosocomial infections by observing good 
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hand hygiene, further benefit from promoting hand hygiene is unlikely, as the margin for 
improvement diminishes. Therefore, if an institution has adequate hand hygiene processes, 
incremental efforts to improve hand hygiene may not be as beneficial as other interventions.
CHG bathing to reduce CDI also showed a lack of efficacy, which was expected because 
CHG does not kill C. difficile spores. In the only CHG study that showed a reduction in CDI 
in acute care hospitals, Rupp et al.,26 speculated that scrubbing in addition to bed bathing 
might reduce the overall presence of spores.
We examined 2 recent systematic reviews on the use of probiotics that found moderate-
quality evidence that probiotics are effective in reducing CDI, but these reviews did not 
specifically examine CDI in acute care hospitals. Given the difference in the type of 
probiotic used here,24–26 it is difficult to interpret the impact of probiotic use in the hospital 
setting. Moreover, given the long duration of intervention in Maziade et al.,24,25 it is difficult 
to assess the impact of confounders over the 10 years of study.
This systematic review focused exclusively on hospital-based interventions with hospital-
based outcomes. These criteria were most apparent in the probiotics category, where only 2 
studies were included, unlike other reviews of probiotics, which included nonhospital-based 
interventions or outcomes.46,47 Another strength of this review is the inclusion of bundled 
interventions, which are commonly used in hospitals. Although a meta-analysis was not 
possible due to the heterogeneity of data, it is valuable to review this emerging category of 
interventions. Another unique feature of this review is the use of the QI-MQCS scale to 
evaluate the quality of studies.
A major limitation is the significant heterogeneity in the interventions and in duration of 
follow-up. There also appears to be considerable publication bias in this area of study. 
Analysis of negative results would be useful. Another limitation is that most studies did not 
separate hospital-onset versus hospital-acquired CDI, and apparently had a mix of cases. 
Therefore, we were unable to separate these subgroups for this review, and we instead used 
the term CDI (in acute care hospitals) to encompass both hospital-onset and hospital-
acquired CDI. Finally, our strict criteria may have led to the exclusion of studies with 
interventions that may be extrapolated to an acute-care hospital setting.
Conclusions and Research Recommendations
This review shows that many interventions can lead to an incremental improvement in CDI 
in acute-care hospitals. Bleach-based daily and terminal cleaning and bundled interventions 
appear to have the best evidence for reduction in CDI. Figure 1 provides a practical 
recommendation based on this update of the CDI intervention literature. Given the relative 
efficacy, institutions should focus on simple, effective interventions, and only consider more 
complex, costly programs if simple interventions have already been adopted. Environmental 
cleaning with bleach-based products carries the most impact and can be easily implemented 
in most institutions. However, some investigators have found that achieving compliance with 
appropriate cleaning technique is difficult outside of the study setting.48 Institutions with 
few resources should strive to improve environmental practices, with implementation of 
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bleach-based cleaning. Institutions with more resources should consider bundled 
interventions that incorporate environmental cleaning, restrictive ASPs, and checklists.
Based on the current literature, there are several interventions, including disposable 
thermometers, hand hygiene, universal gloving, and CHG bathing, that do not need further 
evaluation and have sufficient evidence to make firm recommendations regarding managing 
CDI in acute-care hospitals. In contrast, there is still much to learn about ASPs given the 
heterogeneity of study results. Although Wagner et al.44 concluded that ASPs are not 
effective in impacting the incidence of CDI, there is significant variation in the classes of 
antibiotics studied as wells as the types of ASPs to suggest further study. Other areas for 
future study include the types of audit and feedback used in various interventions hydrogen 
peroxide vapor, dry mist cleaning, UV light disinfection, and checklists. Additionally, as 
most studies on CDI in acute care hospitals are simple pre- and post-intervention designs, 
the use of a step-wedge or parallel cluster design would improve the robustness and quality 
of the data.
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Table 1
Overview of 48 studies included in the qualitative systematic review
Characteristic Studies, N Notes
Total number of hospitals 234
Total number of large hospitalsa 37 Missing: Stone (n = 187), Aldeyab 2011 (n = 3)
Total number of small hospitalsa 5 Missing: Stone (n = 187)
Total number of pre-intervention events 4088 14 studies reporting; others report rates
Total number of postintervention events 2317 14 studies reporting; others report rates
Total number of patient days (pre- and 
postintervention)
2,458,000.25 16 studies reporting; some studies report number of patient days 
without number of events; other studies report number of events 
without number of patient days
a
Large hospitals are defined as having > 200 beds; small hospitals are defined as having ≤ 200 beds.
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